Saint Luke’s Cardiologist Leads Trial to See if Diabetes Drug Can Prevent Serious Covid-19 Complications

Saint Luke’s Mid America Heart Institute and drug company AstraZeneca PLC are conducting a clinical trial to see if a drug now used to treat diabetes could help prevent deadly complications in COVID-19 patients. Read more…